- Home
- SNTI vs COSM Comparison
SNTI vs COSM Comparison
Compare SNTI & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- COSM
- Stock Information
- Founded
- SNTI 2016
- COSM 2009
- Country
- SNTI United States
- COSM United States
- Employees
- SNTI N/A
- COSM N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- SNTI Health Care
- COSM Health Care
- Exchange
- SNTI Nasdaq
- COSM Nasdaq
- Market Cap
- SNTI 19.1M
- COSM 19.4M
- IPO Year
- SNTI N/A
- COSM 2013
- Fundamental
- Price
- SNTI $4.67
- COSM $0.86
- Analyst Decision
- SNTI Strong Buy
- COSM
- Analyst Count
- SNTI 1
- COSM 0
- Target Price
- SNTI $12.00
- COSM N/A
- AVG Volume (30 Days)
- SNTI 115.8K
- COSM 320.4K
- Earning Date
- SNTI 11-14-2024
- COSM 11-14-2024
- Dividend Yield
- SNTI N/A
- COSM N/A
- EPS Growth
- SNTI N/A
- COSM N/A
- EPS
- SNTI N/A
- COSM N/A
- Revenue
- SNTI N/A
- COSM $56,042,109.00
- Revenue This Year
- SNTI $11.52
- COSM $4.53
- Revenue Next Year
- SNTI $78.57
- COSM $25.00
- P/E Ratio
- SNTI N/A
- COSM N/A
- Revenue Growth
- SNTI N/A
- COSM 13.01
- 52 Week Low
- SNTI $1.52
- COSM $0.47
- 52 Week High
- SNTI $16.94
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- SNTI 56.65
- COSM 67.69
- Support Level
- SNTI $3.72
- COSM $0.51
- Resistance Level
- SNTI $4.93
- COSM $0.95
- Average True Range (ATR)
- SNTI 0.46
- COSM 0.08
- MACD
- SNTI 0.01
- COSM 0.02
- Stochastic Oscillator
- SNTI 81.82
- COSM 78.95
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.